Switching from Gilenya to Lemtrada could trigger MS activity
According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
Switching from Gilenya to Lemtrada could trigger MS activity
Switching from Gilenya to Lemtrada could trigger MS activity
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1144 Views
-
Last post by frodo
-
- 0 Replies
- 963 Views
-
Last post by frodo
-
- 0 Replies
- 1056 Views
-
Last post by NHE
-
- 1 Replies
- 1506 Views
-
Last post by ElliotB
-
- 5 Replies
- 13361 Views
-
Last post by gibbledygook